Inventor · disambiguated record
Dirk Strickmann
Also filed as: STRICKMANN DIRK · STRICKMANN DIRK B
3 granted patents·11 pending applications·10 citations·filing 2007–2022
66Inventor score
Files withNabriva Therapeutics GmbH7MANG ROSEMARIE3NABRIVA THERAPEUTICS AG3NABRIVA THERAPEUTICS FORSCHUNG1
Top patents by PatentIndex Score
14 records- 0183US8071643B2Pleuromutilin derivatives for the treatment of diseases mediated by microbesMANG ROSEMARIE·Filed 2008·Granted Dec 6, 2011·6 cites·11 claims
- 0280US8153689B2Pleuromutilin derivatives for the treatment of diseases mediated by microbesMANG ROSEMARIE·Filed 2011·Granted Apr 10, 2012·4 cites·5 claims
- 0373US2022218713A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2022·Application pending·0 cites
- 0470US2021113571A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2020·Application pending·0 cites
- 0568US2020281933A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2020·Application pending·0 cites
- 0664US2020030335A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2019·Application pending·0 cites
- 0763US2019175603A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2019·Application pending·0 cites
- 0863US2014256731A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNABRIVA THERAPEUTICS AG·Filed 2014·Application pending·0 cites
- 0961US2018303842A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNabriva Therapeutics GmbH·Filed 2018·Application pending·0 cites
- 1061US2017266194A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesNABRIVA THERAPEUTICS AG·Filed 2017·Application pending·0 cites
- 1159US2009118366A1Organic compoundsNABRIVA THERAPEUTICS FORSCHUNG·Filed 2007·Application pending·0 cites
- 1258US2013040954A1Pleuromutilin derivatives for the treatment of diseases mediated by microbesMANG ROSEMARIE·Filed 2012·Application pending·0 cites
- 1350US2024208989A1Novel 12-epi-mutilin compounds and uses thereofNabriva Therapeutics GmbH·Filed 2022·Application pending·0 cites
- 1426US9701628B212-epi pleuromutilinsNABRIVA THERAPEUTICS AG·Filed 2015·Granted Jul 11, 2017·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →